Skip to content

Guide

Where to inject peptides: belly, thigh, arm or glute

The four injection sites, how to pinch and angle the needle, how to rotate, which peptides people inject into muscle instead of fat, and which ones you can take without a needle.

Updated 7 min readSources labeled by origin

In this guide · 12 sections

The short answer

Most injectable peptides go into the fat just under the skin, a subcutaneous injection, with a small insulin syringe.

  • Where: the belly, the outer upper thigh or the back of the upper arm. The buttock works too, if you can reach it.
  • How: pinch up about an inch of skin and fat, put the needle in straight (90 degrees), push slowly, pull out.
  • Rotate: a new spot every shot, at least an inch from the last one.

A handful of protocols go into muscle instead, and a few peptides come as sprays, pills or creams. Both are covered below.

Sources for this section (3)
  1. Reference work
    Subcutaneous (SQ) injections(opens in a new tab)

    MedlinePlus · checked

  2. Vendor guide
    Norditropin FlexPro injection instructions(opens in a new tab)

    Novo Nordisk (NovoMedLink) · checked

  3. Regulatory
    Mounjaro and Mounjaro KwikPen label(opens in a new tab)

    DailyMed · checked

Subcutaneous or intramuscular?

Subcutaneous (subQ) means the layer of fat between skin and muscle. It is the route nearly every injected protocol on our compound pages is written for, and the route the approved peptide drugs use: the tirzepatide and somatropin labels both say under the skin.

Intramuscular (IM) means into the muscle itself, with a longer needle. Muscle has more blood flow, so many drugs absorb faster from it. Insulin experts go out of their way to avoid hitting muscle by accident, which is one reason they favor the shortest needles.

For peptides, the rule is simple: use the route the protocol was written for. A subQ dose and an IM dose are not automatically interchangeable. More on intramuscular injection.

Sources for this section (5)
  1. Regulatory
    Mounjaro and Mounjaro KwikPen label(opens in a new tab)

    DailyMed · checked

  2. Vendor guide
    Norditropin FlexPro injection instructions(opens in a new tab)

    Novo Nordisk (NovoMedLink) · checked

  3. Reference work
    Frid AH et al. 2016, New insulin delivery recommendations, Mayo Clin Proc(opens in a new tab)

    PubMed · checked

  4. Reference work
    Subcutaneous (SQ) injections(opens in a new tab)

    MedlinePlus · checked

  5. Competitor guide
    Peptide injections: complete guide(opens in a new tab)

    peptidesexplorer.com · checked

Site 1: the belly

The belly is the default for most people. There is plenty of fat, it is easy to see, and you can pinch it with one hand.

  • Stay below the ribs and above the hip bones.
  • Keep at least 2 inches (5 cm) from the belly button.
  • Skip bruises and any hard or lumpy patch.

A simple rotation is the clock method from one injection guide: picture a clock around your navel and move from 12 to 3 to 6 to 9 o'clock, then go round again an inch further out.

Measured fat depth backs the habit. In an ultrasound study of 388 adults, the subcutaneous layer averaged 13.9 mm on the abdomen against 10.4 mm on the thigh.

Sources for this section (4)
  1. Reference work
    Subcutaneous (SQ) injections(opens in a new tab)

    MedlinePlus · checked

  2. Competitor guide
    Peptide injection sites and rotation guide(opens in a new tab)

    peptiq.io · checked

  3. Clinical study
    Gibney MA et al. 2010, Skin and subcutaneous adipose layer thickness at insulin injection sites, Curr Med Res Opin(opens in a new tab)

    PubMed · checked

  4. Reference work
    Frid AH et al. 2016, New insulin delivery recommendations, Mayo Clin Proc(opens in a new tab)

    PubMed · checked

Site 2: the thigh (how to inject in the thigh)

Use the outer side of the upper thigh, roughly the middle third between hip and knee.

The thigh is the site where an insulin needle most easily reaches muscle. In an ultrasound study, the median distance from skin to muscle was 10.9 mm at the thigh, and the minimum was under 3 mm. An 8 mm needle pushed straight in without a pinch had an estimated 25% chance of going intramuscular in the thigh, against 9.7% on the abdomen.

So in the thigh:

  1. Sit down so the leg is relaxed.
  2. Pinch up a firm fold of skin and fat between thumb and fingers.
  3. Insert straight in, or at 45 degrees if you are lean; the study found a 45 degree angle cuts the risk with longer needles.
  4. Release the pinch, push the plunger slowly, wait a moment, withdraw.

A shorter needle (6 mm instead of 8 mm) also lowers the risk. Length and needle gauge are covered in peptide syringe and needle size.

Sources for this section (4)
  1. Reference work
    Subcutaneous (SQ) injections(opens in a new tab)

    MedlinePlus · checked

  2. Clinical study
    Hirsch L et al. 2014, Intramuscular risk at insulin injection sites, Diabetes Technol Ther(opens in a new tab)

    PubMed · checked

  3. Clinical study
    Gibney MA et al. 2010, Skin and subcutaneous adipose layer thickness at insulin injection sites, Curr Med Res Opin(opens in a new tab)

    PubMed · checked

  4. Competitor guide
    Peptide injection sites and rotation guide(opens in a new tab)

    peptiq.io · checked

Site 3: the back of the upper arm

The arm site is the fleshy back or outer side of the upper arm, at least 3 inches below the shoulder.

It is the hardest site to do on yourself. You need one hand to pinch and the other to inject, and the arm you are injecting cannot help. The tirzepatide label puts it bluntly: inject the abdomen or thigh yourself, or have another person inject the back of the upper arm.

If you inject alone, the belly and thigh are easier; keep the arm for days when someone can help.

Sources for this section (2)
  1. Reference work
    Subcutaneous (SQ) injections(opens in a new tab)

    MedlinePlus · checked

  2. Regulatory
    Mounjaro and Mounjaro KwikPen label(opens in a new tab)

    DailyMed · checked

Site 4: the glute

The buttock is a labeled subcutaneous site for somatropin (growth hormone), along with the back of the upper arm, the abdomen and the thigh.

It also has the most padding. Ultrasound measurements put the median skin-to-muscle distance at the buttock at 16.9 mm, the deepest of the four sites, so an insulin needle is least likely to reach muscle there.

The catch is reach: it is awkward to see and pinch your own glute. It is a good extra site in a rotation, or one for a partner to do.

The glute also shows up in IM protocols, which use a different, longer needle. See the intramuscular section below.

Sources for this section (3)
  1. Vendor guide
    Norditropin FlexPro injection instructions(opens in a new tab)

    Novo Nordisk (NovoMedLink) · checked

  2. Clinical study
    Hirsch L et al. 2014, Intramuscular risk at insulin injection sites, Diabetes Technol Ther(opens in a new tab)

    PubMed · checked

  3. Clinical study
    Gibney MA et al. 2010, Skin and subcutaneous adipose layer thickness at insulin injection sites, Curr Med Res Opin(opens in a new tab)

    PubMed · checked

How to inject subQ: pinch, angle, push

  1. Wash your hands, swab the site and let the alcohol dry completely. Wet alcohol stings.
  2. Pinch about an inch (2.5 cm) of skin and fat, not muscle.
  3. Insert the needle quickly at 90 degrees. Use 45 degrees if there is very little fat to pinch.
  4. Let go of the pinch and push the plunger steadily. One guide suggests taking 5 to 10 seconds rather than jamming it.
  5. Pull the needle straight out. Press lightly with gauze if it bleeds; do not rub.
  6. Drop the syringe straight into a sharps container.

Angles in vaccine guides differ because vaccine needles are longer: CDC uses 45 degrees for a 5/8-inch subQ vaccine needle. With a short insulin needle, straight in is standard.

The full clean routine is in sterile technique for peptide injections.

Sources for this section (3)
  1. Reference work
    Subcutaneous (SQ) injections(opens in a new tab)

    MedlinePlus · checked

  2. Competitor guide
    Peptide injection sites and rotation guide(opens in a new tab)

    peptiq.io · checked

  3. Regulatory
    Vaccine administration (General Best Practice Guidelines for Immunization)(opens in a new tab)

    CDC · checked

Rotate every shot

Hitting the same spot over and over builds lipohypertrophy: rubbery lumps of fat that absorb medication unevenly. In a study of 430 insulin users, about two-thirds had these lumps; among people who rotated correctly, only 5% did. Expert insulin guidance says never to inject into such a lump.

How to rotate:

  • Each new shot at least 1 inch from the last.
  • Work round one area in a set order (the belly clock), then move to another area.
  • Same area is fine, same spot is not. The tirzepatide label says to rotate sites with each dose, and Lilly adds that you may stay in the same body area as long as the spot changes.

More on injection site rotation.

Sources for this section (5)
  1. Clinical study
    Blanco M et al. 2013, Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes, Diabetes Metab(opens in a new tab)

    PubMed · checked

  2. Reference work
    Frid AH et al. 2016, New insulin delivery recommendations, Mayo Clin Proc(opens in a new tab)

    PubMed · checked

  3. Reference work
    Subcutaneous (SQ) injections(opens in a new tab)

    MedlinePlus · checked

  4. Regulatory
    Mounjaro and Mounjaro KwikPen label(opens in a new tab)

    DailyMed · checked

  5. Vendor guide
    Information for a patient who injects Zepbound beyond the label language(opens in a new tab)

    Lilly Medical · checked

Which peptides people inject into muscle

A few protocols on our compound pages use IM injection. All of them come from guides or community reports, apart from one small human study:

  • TB-500: subQ is the default, and guides note that some people inject it into muscle instead.
  • PEG-MGF and IGF-1 LR3: injected into the muscle just trained, after a workout, per community and guide protocols. Some PEG-MGF users go subQ into the belly instead.
  • Follistatin-344: community protocols put it into the deltoid, outer thigh or upper glute before training.
  • NAD+ and glutathione: guides list IM and subQ side by side. On r/Peptides, people describe IM glutathione shots into the thigh.
  • Epitalon: one published human study gave it by IM injection; guides use subQ.

IM needs a different needle. CDC gives 22 to 25 gauge for intramuscular shots, 5/8 to 1.5 inches long for an adult deltoid depending on body weight and 1.5 inches for the thigh, inserted at 90 degrees. A 5/16-inch insulin needle is built to stay in fat, not reach muscle.

Sources for this section (10)
  1. Competitor guide
    TB-500 dosage chart(opens in a new tab)

    peptidedeck.com · checked

  2. Community-reportedvia competitor guide
    PEG-MGF community protocols(opens in a new tab)

    Peptide Protocol Wiki · checked

  3. Competitor guide
    IGF-1 LR3 dosage guide(opens in a new tab)

    BodyHackGuide · checked

  4. Community-reportedvia competitor guide
    Follistatin-344 dosing guide(opens in a new tab)

    The Peptide Catalog · checked

  5. Competitor guide
    NAD+ Quick Start(opens in a new tab)

    peptidedosingprotocols.com · checked

  6. Competitor guide
    Glutathione dosing(opens in a new tab)

    peptideprotocolwiki.com · checked

  7. Community-reported
    Glutathione Sub Q (comment: 1 mL twice a week)(opens in a new tab)

    r/Peptides · checked

  8. Clinical study
    Korkushko 2007, melatonin in monkeys and elderly people(opens in a new tab)

    PubMed · checked

  9. Clinical studyvia reference work
    Jain et al. 2026, epitalon and epithalamin narrative review (full text)(opens in a new tab)

    PubMed Central · checked

  10. Regulatory
    Vaccine administration (General Best Practice Guidelines for Immunization)(opens in a new tab)

    CDC · checked

Where to inject tirzepatide, retatrutide, HGH and MOTS-c

  • Tirzepatide: the label says abdomen or thigh, or the back of the upper arm if someone else injects. Lilly reports similar exposure from all three sites, so pick by comfort and rotate weekly.
  • Retatrutide: no label yet. The trials gave it as a once-weekly subcutaneous shot. With no label, the tirzepatide sites are the natural reference: belly, thigh, back of the arm.
  • HGH (somatropin): the Norditropin label lists the back of the upper arm, abdomen, buttocks or thigh, and the maker says to change the site every day.
  • MOTS-c: guides use subQ and name no special site. Belly or thigh, rotated, is the usual approach.

For almost every other peptide the answer is the same: subQ, belly first, rotate.

Sources for this section (6)
  1. Regulatory
    Mounjaro and Mounjaro KwikPen label(opens in a new tab)

    DailyMed · checked

  2. Vendor guide
    Information for a patient who injects Zepbound beyond the label language(opens in a new tab)

    Lilly Medical · checked

  3. Clinical study
    Jastreboff AM et al. 2023, Triple-hormone-receptor agonist retatrutide for obesity: a phase 2 trial, N Engl J Med(opens in a new tab)

    PubMed · checked

  4. Clinical studyvia vendor guide
    Preliminary results of retatrutide from TRIUMPH-1(opens in a new tab)

    Lilly Medical · checked

  5. Vendor guide
    Norditropin FlexPro injection instructions(opens in a new tab)

    Novo Nordisk (NovoMedLink) · checked

  6. Competitor guide
    MOTS-c quick start protocol(opens in a new tab)

    peptidedosingprotocols.com · checked

Do you have to inject peptides?

Not always. It depends on the peptide and on whether a non-injected form has been tested.

  • Oral: semaglutide has an approved tablet. It works only with an absorption enhancer (SNAC) and strict rules: empty stomach, up to 4 ounces of plain water, nothing else for 30 minutes. Even then, the Rybelsus label puts absolute bioavailability at about 0.4% to 1%, which is why tablet doses are far larger than injected ones. Guides pitch oral BPC-157 capsules mainly at gut problems.
  • Nasal: Semax and Selank are sold in Russian pharmacies as nasal drops. PT-141 has been tested as a nasal spray in trials.
  • Topical: GHK-Cu is widely sold in creams and serums for skin. LL-37 was tested as a gel on leg ulcers.

For most research peptides, though, injection is what the guides and doses are written for. A dose for one route does not carry over to another, so never reuse an injected dose as an oral or nasal one.

Sources for this section (9)
  1. Regulatory
    Rybelsus and Ozempic tablets label(opens in a new tab)

    DailyMed · checked

  2. Regulatory
    Wegovy injection and tablets label (SPL v19, Jun 30 2026)(opens in a new tab)

    DailyMed · checked

  3. Competitor guide
    BPC-157 oral vs injection(opens in a new tab)

    peptidesexplorer.com · checked

  4. Regulatoryvia vendor guide
    Semax instruction for use (English translation of the Russian label)(opens in a new tab)

    Peptogen (label translation) · checked

  5. Regulatoryvia reference work
    Selank 0.15% nasal drops(opens in a new tab)

    Vidal · checked

  6. Clinical study
    Intranasal PT-141 in healthy men and patients with erectile dysfunction (Int J Impot Res 2004)(opens in a new tab)

    PubMed · checked

  7. Competitor guide
    GHK-Cu cream(opens in a new tab)

    peptidedeck.com · checked

  8. Clinical study
    Gronberg A et al. 2014, LL-37 in hard-to-heal venous leg ulcers, Wound Repair Regen(opens in a new tab)

    PubMed · checked

  9. Competitor guide
    Peptide injections: complete guide(opens in a new tab)

    peptidesexplorer.com · checked

Mistakes to avoid

  • Injecting into a lump, scar or bruise. Absorption from a lump is unpredictable.
  • Using the same spot every time because it hurts least.
  • Going straight into a lean thigh with no pinch.
  • Using an insulin syringe for an IM protocol, or an IM needle for a subQ one.
  • Reusing a needle. Makers say insulin needles are single-use and no longer sterile after one shot.
  • Injecting through wet alcohol.
Sources for this section (4)
  1. Reference work
    Frid AH et al. 2016, New insulin delivery recommendations, Mayo Clin Proc(opens in a new tab)

    PubMed · checked

  2. Clinical study
    Hirsch L et al. 2014, Intramuscular risk at insulin injection sites, Diabetes Technol Ther(opens in a new tab)

    PubMed · checked

  3. Vendor guide
    Insulin syringes with Ultra-Fine needle(opens in a new tab)

    embecta · checked

  4. Reference work
    Subcutaneous (SQ) injections(opens in a new tab)

    MedlinePlus · checked

Peptides this guide covers

First published . Not medical advice. Sources are labeled by origin so you can judge them yourself.